APA (7th ed.) Citation

JJ, C., AD, S., AF, L., MS, E., AM, N., HJ, H., . . . M, D. (2016). Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature communications, 7, 11815. https://doi.org/10.1038/ncomms11815

Chicago Style (17th ed.) Citation

JJ, Chabon, et al. "Circulating Tumour DNA Profiling Reveals Heterogeneity of EGFR Inhibitor Resistance Mechanisms in Lung Cancer Patients." Nature Communications 7 (2016): 11815. https://doi.org/10.1038/ncomms11815.

MLA (9th ed.) Citation

JJ, Chabon, et al. "Circulating Tumour DNA Profiling Reveals Heterogeneity of EGFR Inhibitor Resistance Mechanisms in Lung Cancer Patients." Nature Communications, vol. 7, 2016, p. 11815, https://doi.org/10.1038/ncomms11815.